View our newly released 8th edition, a practical overview of Australia's Insurance Contracts Act 1984.
Lynne has a strong track record across all aspects of patent protection, commercialisation and enforcement. She regularly assists clients with freedom to operate advice, protection and filing strategies, commercialisation, and Australian and multi-jurisdictional enforcement. She is adept at handling complex patent litigation on behalf of local and international clients, including co-ordinating with international counsel as part of a global litigation strategy.
A particular focus of Lynne’s practice is acting for and advising clients in relation to patents in the pharmaceutical, biotechnology, industrial, mechanical, software industries and in relation to business methods for financial services organisations.
Areas of expertise include:
Lynne assists clients in determining and implementing strategies for the management of advertising campaigns in a range of industries including the fast moving consumer goods, food and beverage, pharmaceutical and automotive industries. Brands Lynne has acted for include: Specsavers, Allianz, Gillette, Nestle, Colgate, Abbey National plc, Wyeth, Jim Beam, Bacardi, Nike, Yum! and PepsiCo.
A member of the Franchise Consultative Committee, Lynne advises and acts for clients in relation to commercial contracting, distribution arrangements and franchising. She advises on matters including drafting and negotiation of large scale distribution agreements; negotiating supply and logistics agreements; establishment and structuring of franchise systems; drafting franchise agreements and disclosure documents; and termination of franchisees and distributors and associated litigation.
Lynne has advised franchisors such as Baskin-Robbins, Dunkin' Donuts, KFC, Pizza Hut, Ikea, Peugeot, Giorgio Armani and a number of financial institutions, on operation of franchise, distribution and logistics operations.
A specialist in pharmaceutical, biotechnology and medical device regulation, Lynne represents pharmaceutical companies in relation to the registration of therapeutic goods and devices, the inclusion of goods on the Pharmaceutical Benefits Scheme and drafting and negotiation of key commercial and logistic agreements.
Lynne's practice in this area includes:
• advising clients on regulatory compliance in relation to product registration, claims, labelling, distribution channels, trade promotions, selling techniques, pricing and data privacy• advising and representing clients in respect of allegations of breach of the Therapeutic Goods Act, Therapeutic Goods Advertising Code; the Medicines Australia Code of Conduct and the ASMI Code• acting for clients in Federal Court administrative law actions challenging Government pricing and registration decisions• acting for clients in large scale litigation to enforce IP rights including patents, trade marks, copyright and confidential information• appearing before government enquiries in relation to the funding and regulation of medical devices in Australia
Lynne has a highly successful record in litigating to enforce IP rights including patents, designs, trade marks, copyright, and confidential information.
Lynne is currently involved in numerous high-profile disputes including acting for Specsavers in the Federal Court relating to allegations of infringement of copyright and misuse of confidential information and for Zurich in Federal Court litigation relating to allegations of trade mark infringement by an Australian company trading under the name Zurich Securities. The Zurich case involves the protection of one of the world’s best known financial services trade marks and will be one of the first cases in Australia to define the ambit of what is a "well known" trade mark in Australia and the scope of the related services provisions of the Trade Marks Act.
Lynne is an experienced and respected advisor in the area of intellectual property. She is particularly recognised for her work in trade marks, patents, breach of confidence and advertising litigation.
Lynne specialises in the health and ageing sector and provides litigation and commercial advice to the pharmaceutical, biotechnology and medical devices industries. She also acts for a broad range of clients across the fast moving consumer goods, automotive, aviation, fashion, food and beverages, financial services, mining, and telecommunications industries.
Lynne’s practice encompasses all aspects of the creation, acquisition, commercialisation, management, protection and enforcement of intellectual property rights. She provides day-to-day advice to clients including Qantas, AMEX, Nielsen, SingTel Optus, Scholastic and AMP/AXA, in relation to the development and protection of intellectual property rights and complex trade mark portfolios.
A sought after litigator, Lynne regularly represents clients in complex multi-jurisdiction litigation. She acts for clients in litigation to enforce IP rights including patents, designs, trade marks, copyright, confidential information and in actions relating to allegations of misleading and deceptive conduct.
Clients regularly seek Lynne's advice on advertising clearance and disputes and she has acted for companies in landmark cases including representing Gillette before the Full Federal Court in the Duracell Bunny case which set the benchmark for comparative advertising in Australia.
Lynne has been recognised by her peers in Chambers Global 2011 as an experienced trade mark specialist and "an extremely motivated and highly capable lawyer" and listed as a recommended lawyer for Patent Litigation by PLC 2010.
Based on her extensive experience acting for franchisors and representing their interests in policy and legislative change debate, Lynne was appointed by the ACCC as a member of the Franchise Consultative Committee. She is also a current member of INTA, IPSANZ and LES.
Lynne is the head of Minter Ellison's Trade Marks practice. She provides ongoing strategic advice to clients in relation to the development and protection of intellectual property rights. Her expertise includes the registration and management of trade mark portfolios and the enforcement of copyright, trade marks, designs and patents.